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996Objective: Reports of minimally invasive tricuspid valve operations are rare, and results are often contradictory.
This study analyzes our 5-year experience with minimally invasive tricuspid valve operations in high-risk
patients.
Methods: Between November 2005 and December 2011, tricuspid valve surgery using a nonsternotomy
minimally invasive technique was performed in 64 patients (19 male, 45 female; mean age,
63.2  12.8 years). Mean preoperative European System for Cardiac Operative Risk Evaluation was
7.3  2.9, and predicted mortality was 11.6%  11.7%. Tricuspid valve regurgitation cause was functional
in 36 patients (56.2%), endocarditis in 2 patients (3.1%), and rheumatic in 24 patients (37.5%). Two patients
(3.1%) showed prosthesis dysfunction. Forty patients (62.5%) had undergone previous cardiac surgery.
Results: Tricuspid valve repair was performed in 35 patients (54.7%). Tricuspid valve replacement with bio-
prosthesis was performed in 27 patients (42.2%), and the remaining 2 patients (3.1%) underwent bioprosthetic
replacement. Concomitant procedures (48) included mitral valve surgery (42 patients), atrial septal defect
closure (5 patients), and myxoma exeresis (1 patient). Conversion to sternotomy occurred in 1 patient
(1.6%). Overall hospital mortality was 7.9%. Stroke occurred in 1 patient (1.6%), and 5 patients underwent
reoperation for bleeding (7.8%). Mean follow-up time was 21  16 months (range, 1-59 months) and 100%
completed. Cumulative Kaplan–Meier estimated 5-year survival was 81.3%, and 5-year freedom from reoper-
ation was 100%.
Conclusions: The heart-port–based minimally invasive approach seems to be safe, feasible, and reproducible in
case of tricuspid valve operations. It ensures low perioperative morbidity, moderate to low rates of tricuspid
regurgitation recurrence, and low late mortality. It also seems to have an added value in case of reoperative
procedures. (J Thorac Cardiovasc Surg 2014;147:996-1001)Right-sided cardiac valvular disease has traditionally been
considered less clinically important than mitral or aortic
valve pathology, and its optimal management remains con-
troversial. Patients are rarely referred for isolated surgical
tricuspid valve (TV) repair or replacement, and most proce-
dures are done in the context of other planned cardiac
surgery.
However, significant tricuspid regurgitation (TR) can
lead to functional impairment and has an adverse impact
on perioperative outcomes, functional class, and survival.1
Approximately 90% of cases of TR are secondary to left
heart pathology with various degrees of pulmonary hyper-
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presence of pulmonary hypertension, cardiac output
declines and right heart failure worsens.
Although TR leads to a dismal prognosis after symptom
development and in-hospital mortality and actuarial sur-
vival are improved in patients undergoing TVannuloplasty
at the time of mitral valve (MV) surgery, TR remains fre-
quently undertreated.
Because TR can vary according to the preload, afterload,
and right ventricular function,3-5 the assessments of leaflet
morphology, annular dimension (from the middle part of
the septal annulus to the middle part of the anterior
annulus), and pulmonary artery pressure are particularly
important for determining subsequent management. It has
been suggested that a tricuspid annulus diameter greater
than 40 mm or 21 mm/m2 measured in the 4-chamber
view should indicate the need for TV repair6 and that TV re-
pair should be accomplished in patients with preoperative
atrial fibrillation (AF).
Management guidelines indicate a move toward more ag-
gressive treatment of TR.7 For patients undergoing left-side
valve surgery, TV repair or replacement is universally rec-
ommended in the presence of severe TR or tricuspid annular
dilatation because it does not resolve spontaneously after
correction of MV disease as once believed.1,8,9 In thoseery c March 2014
Abbreviations and Acronyms
AF ¼ atrial fibrillation
ASD ¼ atrial septal defect
MV ¼ mitral valve
NYHA ¼ New York Heart Association
TR ¼ tricuspid regurgitation
TV ¼ tricuspid valve
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presence of symptoms or progressive right ventricular
dilatation or dysfunction.2,3,5,7,8,10-12
Because reoperation for recurrent isolated TR carries
high mortality rates (up to 37%), TV surgery is not rou-
tinely offered to many patients.11,13 As minimally invasive
approaches for treatment of aortic and MV disease are
developing, parallel alternative approaches for TR may be
necessary, especially for those patients with high surgical
risk.
Since 2005 we have performed TVoperations, isolated or
in association with other procedures, through a right mini-
thoracotomy using the heart-port platform as the procedure
of choice. In this report, early and long-term results of this
approach in high-risk patients are examined.A
C
DMATERIALS AND METHODS
Between November 2005 and December 2011 at the University of
Turin, 64 patients (19 male, 45 female; mean age, 63.2  12.8 years) un-
derwent TV surgery through a lateral right mini-thoracotomy using a non-
sternotomy minimally invasive technique. During the same study period,
294 patients underwent TV procedures (combined or isolated) through
a standard median sternotomy. The number of TV surgeries in median ster-
notomy progressively and significantly decreased. For the past 2 years, all
isolated TVoperations have been performed with a minimally invasive ap-
proach, and combined procedures with the same technique significantly in-
creased in the study period (data not shown). Data from all patients were
retrospectively reviewed. Preoperative clinical and echocardiographic
characteristics are listed in Table 1. Mean preoperative additive European
System for Cardiac Operative Risk Evaluation was 7.3  2.9, and logistic
European System for Cardiac Operative Risk Evaluation was
11.6%  11.7%. Predicted mortality of patients undergoing isolated TV
surgeries (16 patients) and patients undergoing concomitant mitral proce-
dures (48 patients) was 9.01%  2.25% and 12.52%  13.02%, respec-
tively (P<.05). Mean New York Heart Association (NYHA) functional
class was 2.8  0.9 (median, 3; range, 1-4). More than 50% of patients
(37/64) were in NYHA class III or IV. AF was present in 43 patients
(67.2%). Mean preoperative degree of TRwas 3.3 1.1 (median, 4; range,
3-4). Mean left ventricular ejection fraction was 58.7%  3.5%. Pulmo-
nary hypertension (defined as systolic pulmonary artery pressure
60 mm Hg) was measured in 27 patients (42.2%).
TR severity was based on the absolute size of the regurgitant jet by color
flow imaging, the relative size of the regurgitant jet (relative to the right
atrium area), and the hepatic venous flow pattern, as recommended by
the guidelines of the American Society of Echocardiography.14,15 In
addition, tricuspid annulus diameter was measured in the 4-chamber
view to confirm the need for TV repair. In our series, mean TV annulus
diameter, measured by echocardiography, was 45.5  7.2 mm.The Journal of Thoracic and CaTV regurgitation causewas functional in 36 patients (56.3%), due to en-
docarditis in 2 patients (3.1%), and due to rheumatic disease in 24 patients
(37.5%). Two patients (3.1%) showed prosthesis dysfunction.
Forty patients (62.5%) underwent reoperations, 8 (20.0%) of whom
had undergone 2 previous cardiac surgeries and 12 (30.0%) of whom
had undergone 3 or more previous operations; all were valve surgeries,
with no previous CABG. In 12 patients (30.0%), it was a previous TV
procedure: 2 TV replacements, 1 TV exeresis for endocarditis, and 9 TV
repairs (2 Kay procedures and 7 De Vega procedures).
Isolated TV regurgitation was present in 16 patients (25.0%). One of
these patients had prosthesis valve deterioration. Concomitant cardiac dis-
eases were diagnosed in the remaining 48 patients (75.0%). A total of 42
patients (65.6%) had concomitant severe mitral regurgitation (native MV
regurgitations in 28, prosthesis valve deterioration in 9, and mechanical
prosthesis dysfunction in 5). Five patients (7.8%) had a concomitant patent
foramen ovale or an atrial septal defect (ASD), and 1 patient had a left atrial
myxoma (1.5%).
All patientswere screened preoperatively for adequatevascular access by
an additional aorto-iliac and femoral artery angiography at the time of car-
diac catheterization or by angio-computed tomography scan.Arterial cannu-
lation was obtained through the femoral artery with an Endo-return cannula
(EndoReturn arterial cannula 21F or 23F; Edwards Lifesciences, Irvine,
Calif) in 43 patients (67.2%) and a standard femoral cannula in 16 patients
(15.6%). In 5 patients (7.8%), direct transthoracic aortic cannulation was
obtained with the EndoDirect cannula (EndoDirect arterial cannula 24F;
Edwards Lifesciences). In case of cannulation with the EndoReturn and En-
doDirect systems, aortic clamping was obtained with endoaortic balloons
(EndoClampaortic catheter, EdwardsLifesciences). In case of standard fem-
oral artery cannulation, a Chitwood transthoracic clamp (Scanlan Interna-
tional, St. Paul, Minn) was used. The decision on the type of clamping to
use (EndoReturn clamp, EndoDirect clamp, Chitwood clamp) was based
on the anatomy of the sinotubular junction, the aorto-iliac-femoral anatomy,
the chest structure, and history of cardiothoracic procedures. For example, in
case of tortuous and atheromatous aorto-iliac-femoral anatomy, an endovas-
cular clamping technique with the EndoDirect kit was preferred; in case of
previous cardiac procedures with a normal vascular anatomy, a peripheral
endovascular approach (EndoReturn)waspredominantly; in caseof a dilated
ascending aorta (diameter>38-40 mm), a Chitwood transthoracic clamp
was predominantly used. The selection of clamps was patient oriented and
independent of the learning curve.
Venous return was routinely obtained with a double cannulation (jugular
and femoral). Jugular cannulation was always achieved percutaneously
using a 17F or 21F Medtronic (Minneapolis, Minn) cannula or a 18F or
20F Edwards Lifesciences cannula (OptiSite). Femoral cannulation was
performed percutaneously in all cases of simultaneous EndoDirect aortic
cannulation. In case of EndoReturn or standard femoral artery cannulation,
a minimal (3 cm) groin incision was necessary, and both arterial and fem-
oral cannulations were directly performed using the Seldinger technique
through two 4/0 Prolene purse strings. Femoral vein cannulation was
obtained with QuickDraw venous cannulas (Edwards Lifesciences). The
technique of direct aortic cannulation with the EndoDirect system has
been described by Glower and colleagues.16,17 The port access surgical
technique used at the University of Turin has been described.18 Before
opening the right atrium, the superior and inferior venae cavae were oc-
cluded. Snaring was obtained by placing tourniquets around the superior
and inferior venae cavae in 56 patients (87.5%) or placing endovascular
balloons (7F, 65 cm; Boston Scientific, Natick, Mass) in 8 patients
(12.5%). The endovascular balloons are delivered under transesophageal
echocardiography into the right atrium from the right femoral vein (through
a 7F introducer) and from the right jugular vein (through a Y-modified can-
nula). This last approachwas preferred in case of previous cardiac surgeries
to avoid dangerous dissections. In case of concomitant operation (MV or
myxoma), the left atrium was accessed first. After completing the left-
sided operation, the left atrium was closed and complete de-airing wasrdiovascular Surgery c Volume 147, Number 3 997
TABLE 1. Preoperative clinical and echocardiographic character-
istics (N ¼ 64 patients)
Age, y (mean, SD) 63.2  12.8
Female sex (n,%) 45 (70.3%)
Diabetes (n,%) 12 (18.7%)
Renal failure (n,%) 9 (14.1%)
Hypertension (n,%) 42 (65.6%)
COPD (n,%) 3 (4.7%)
Pulmonary hypertension (60 mm Hg) (n,%) 27 (42.2%)
AF (n,%) 43 (67.2%)
Cumulative additive euroSCORE (mean, SD) 7.3  2.9
Cumulative log euroSCORE (mean, SD) 11.6  11.7
NYHA class (mean, SD) 2.8  0.9
class I/II (n,%) 27 (42.2%)
class III/IV (n,%) 37 (57.8%)
TV grade (mean, SD) 3.3  1.1
TV annulus (mm) (mean, SD) 45.5  7.2
Ejection fraction (mean, SD) 58.7  3.5
Ejection fraction<50% 7 (10.9%)
Native MV disease 28/64 (43.7%)
MV stenosis 10/28 (35.7%)
MV regurgitation 18/28 (64.3%)
Redo (n,%) 40 (62.5%)
1st redo (n,%) 20/40 (50%)
2nd redo (n,%) 8/40 (20%)
3rd or more redo (n,%) 12/40 (30%)
SD, Standard deviation; COPD, chronic obstructive pulmonary disease; AF, atrial
fibrillation; euroSCORE, European System for Cardiac Operative Risk Evaluation;
NYHA, New York Heart Association; TV, tricuspid valve; MV, mitral valve.
TABLE 2. Type of surgical procedures and operative data (n, %)
(N ¼ 64 patients)
TV repair 35 (54.7%)
Annular ring 33/35 (94.3%)
De Vega annuloplasty 2/35 (5.7%)
TV replacement 27 (42.2%)
Tricuspid prosthesis replacement 2 (3.1%)
Isolated TV procedures 16 (25%)
Combined procedures 48 (75%)
MV repair 14 (29.2%)
MV replacement 14 (29.2%)
Mitral prosthesis replacement 14 (29.2%)
ASD closure 5 (10.4%)
Myxoma resection 1 (2%)
TV procedures on beating heart 33 (51.5%)
Isolated TV procedures on beating heart 16/16 (100%)
Combined procedures on beating heart 17/48 (35.4%)
AF cryoablation 5/43 preoperative
AF (11.6%)
Conversion to sternotomy 1 (1.6%)
TV, Tricuspid valve;MV,mitral valve; ASD, atrial septal defect; AF, atrial fibrillation.
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formed on the beating heart in 33 patients (51.5%) (16 isolated TV surger-
ies, 17 concomitant TV surgeries).
After hospital discharge, all patients underwent annual follow-up. Post-
operative NYHA class was evaluated, and echocardiographic examination
was performed in all cases. This retrospective study was approved by our
institutional ethics committee (institutional review board).
Statistical Analysis
Descriptive statistics for categoric variables are reported as frequency
and percentage, and continuous variables are given as mean and standard
deviation. Survival was calculated using the Kaplan–Meier method. Com-
parison between patients who were treated for isolated TV disease and
thosewho had concomitant procedures and between TV repair and replace-
ment were made using the log-rank test.
RESULTS
TV repair was performed in 35 patients (54.7%). In 33 of
35 cases, a prosthetic ring was used (mean ring size,
30.7  2.0; range, 28-34), whereas in the remaining 2
patients a De Vega annuloplasty was carried out. Three of
35 were TV re-repairs with prosthetic ring positioning
(2 previous De Vega procedures and 1 Kay procedure).
TV replacement with bioprosthesis was performed in 27 pa-
tients (42.2%), whereas the remaining 2 patients (3.1%) un-
derwent bioprosthetic replacement (mean prosthetic size,
29.1  2.5; range, 25-33). Concomitant procedures (48/64
cases) included MV surgery (14 MV repairs, 14 MV998 The Journal of Thoracic and Cardiovascular Surgreplacements, and 14 mitral prosthesis replacements),
ASD closure (5 patients), and myxoma exeresis (1 patient).
Surgical cryoablation of AF was performed in only 5 pa-
tients (5/43, 11.6%). The remaining 38 patients (88.4%)
were not treated for AF because of a left atrium diameter
grater than 60 mm and a long-standing persistent AF.
At the end of the procedure, intraoperative transesopha-
geal echocardiography showed no or trivial TV regurgita-
tion in all patients who underwent TV repair (35 patients).
No leaks were observed in case of TV (27 patients) or
prosthetic replacement (2 patients).
Mean duration of cardiopulmonary bypass was
135.4  41.9 minutes. In patients undergoing operation
for concomitant procedures, the mean crossclamp time
was 87.4  27.4 minutes (48/64 patients: 75%); in such
cases, tricuspid surgery was then performed on beating
heart in 17 patients (17/48 [36.2%]). All the isolated TV
procedures (16 patients) were carried out on pump and on
beating heart.
Conversion to sternotomy occurred as the result of strong
right chest adhesions in 1 patient (1.6%) who had under-
gone previous cardiac surgery. No other complications oc-
curred during surgery. Operative characteristics are listed
in Table 2.
Perioperative morbidity was relatively low (Table 3). A
major neurologic event (stroke) occurred in 1 patient
(1.6%) who underwent standard femoral artery cannulation
with a transthoracic aortic clamp. Five patients underwent
reoperation for bleeding (7.8%). Hemodialysis for acute re-
nal failure was necessary in 5 patients (7.8%). One patient
(1.6%) required pacemaker positioning for atrioventricular
block. All 5 patients who underwent AF cryoablation were
in sinus rhythm at discharge. New postoperative onset of AFery c March 2014
TABLE 3. Postoperative outcomes (N ¼ 64 patients)
Hospital mortality (n,%) 5 (7.8%)
Length of postoperative stay (d) (mean, SD, median) 14.1  19.0 (8)
Reoperation for bleeding (n,%) 5 (7.8%)
Stroke (n,%) 1 (1.6%)
Acute renal failure (n,%) 5 (7.8%)
Blood loss (mL) 471  382
Pacemaker requirement (n,%) 1 (1.6%)
SD, Standard deviation.
FIGURE 1. Cumulative Kaplan–Meier estimate survival (dashed line).
Kaplan–Meier survival for patients who underwent isolated TV surgery
(continuous line) and combined procedures (dotted line).
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Doccurred in 11 patients (17.2%) with conversion to sinus
rhythm after intravenous amiodarone administration in all
cases.
Median intensive care unit stay was 1.0 day, and median
postoperative hospital stay was 8 days. Mean drain blood
loss was 471.5  382.5 mL. Overall hospital mortality, de-
fined as death at any time before discharge from the hospital
or within 30 days of operation, was 7.8% (5/64 patients)
(Table 3). The causes of death were mainly related to severe
heart failure and poor cardiac output with consequent multi-
organ failure (3 cases); 1 patient died of sepsis, and 1 patient
died after a major neurologic event. Patients who underwent
TV repair had a hospital mortality of 2.8% (1/35 patients),
and patients who underwent TV replacement had a hospital
mortality of 13.8% (4/29 patients). Patients who underwent
isolated TV procedures had no hospital mortality, and pa-
tientswho underwent associated TVprocedures had a hospi-
tal mortality of 10.4% (5/48 patients). All patients
discharged were followed up for 21.5  36.9 months.
Early and late postoperative echocardiographic analyses
showed trivial or no regurgitation in 62 patients (96.9%);
only 2 patients with their TV repaired had mild TR (data
not shown). Mean NYHA functional class at follow-up
was 1.4  0.7.
Freedom from reoperation for TV disease was 100%.
Kaplan–Meier analysis revealed an overall 5-year survival
of 81.3% and a 5-year freedom from reoperation of
100%. Survival at 5 years was 76.6% for patients undergo-
ing combined surgery versus 94.1% for patients undergoing
tricuspid surgery alone (P ¼ .17) (Figure 1).
The comparison between patients who underwent iso-
lated TV surgeries and patients who underwent combined
procedures in regard to preoperative patient characteristics,
echocardiographic measurements, and intraoperative and
postoperative findings revealed no statistical difference ex-
cept for predictive mortality, which was 9.01%  2.25%
and 12.52%  13.02%, respectively (P< .05) (data not
shown).DISCUSSION
The tricuspid valve has been commonly referred to as the
forgotten valve in comparison with the left-sided valves.
Nevertheless, the TVis gainingmore attention. Cardiac oper-
ation through a right mini-thoracotomy has been usedThe Journal of Thoracic and Caincreasingly bymany centers in theworld. Excellentmidterm
results have been published for MV operations using this
technique.19-21 Most of these studies reported less wound
infection, less bleeding, less pain, and a more expeditious
return to normal life. However, data are lacking on
TV operations using a minimally invasive approach.
Cardiologists and cardiac surgeons increasingly recognize
it has an important entity in structural heart disease.22
We present our results on a series of minimally invasive
TVoperations during a 5-year period. We have considered
both TV operations and tricuspid operations associated
with other cardiac procedures, such as MV repair/replace-
ment, ASD closure, and myxoma removal. The aim of our
study is to demonstrate the feasibility, effectiveness, and
safety of such interventions using the port access platform
in patients at high surgical risk. Furthermore, a brief com-
parison between isolated versus combined tricuspid surger-
ies was done and revealed no differences in terms of
preoperative, intraoperative, and postoperative characteris-
tics. The only statistically significant variable was the pre-
dicted mortality, which was higher in the combined group
versus isolated tricuspid procedures. This difference did
not affect the intraoperative and postoperative results.
The percentage of TV repair is low in our series (35 over
a total of 64 cases). This is in part due to the patients who
had undergone previous TV replacement (2 patients) and
those who had rheumatic disease (24 patients) and endocar-
ditis (2 patients). By keeping this in mind, the percentage of
patients receiving TV repair is approximately 100% (35/36:
97.2%), far more than previously reported by other authors
for isolated TV surgeries.4,22-24 All 36 had functional TRs.
TV repair was performed even in those patients who
underwent previous TV repair. This result confirms that
a TV repair was performed when possible and that it is
feasible with a minimally invasive approach. A rightrdiovascular Surgery c Volume 147, Number 3 999
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and its apparatus, ensuring the performance of any surgical
procedure and thus increasing the repair rate.
In this study, few patients were treated for AF. An MV
procedure was associated in all cases. The decision not to
treat AF was made in those patients with an extremely en-
larged left atrium (>60 mm or>100 mL) and in those
who had undergone previous cardiac procedures. In this
case, the port-access technique allows the TV to be operated
with limited dissection of adhesions. AF treatment requires
more extensive isolation of cardiac structures, and this can
be extremely dangerous in up to 3 re-do operations.
Although Lee and colleagues22 demonstrated different
findings, in our experience, the cardiopulmonary bypass
and aortic clamp times are acceptable and comparable to
the operative results reported by other authors in case of
operationperformed throughamedian sternotomy23oramin-
imally invasive approach for isolated TV procedures.4 These
data are encouraging considering that additional cardiac pro-
cedures were associated with TV surgery and that in most of
the cases (62.4%) a previous cardiac procedure was done.18
We found a low incidence of postoperative adverse
events compared with other reported series.22 Major neuro-
logic complications occurred in only 1 case in which a fem-
oral cannulation was used. The event could have been
a consequence of peripheral cannulation and retrograde per-
fusion. Peripheral cannulation was associated with a higher
incidence of stroke in some early reports of valve surgery
through a right mini-thoracotomy.18,25,26 The rate of
reoperation for bleeding still remains slightly high (7.5%)
but in line with other series.22 All patients who underwent
reoperation for bleeding were redo cases. This could be
explained by the fact that more than 60% were redo cases
(up to 3 redo cases in 30% of the patients) with the need
for dissection of strong adhesions. In the first phase of our
experience, caval snaring was obtained by putting tapes
around both venae cavae with the need of extended dissec-
tions. Since 2008, we have adopted a new technique of
bicaval snaring using endovascular balloon catheters
(Equalizer Occlusion Balloon Catheter; Boston Scientific)
that ensure endocaval occlusion with no need for extensive
dissections. We have adopted this system in redo cases with
success. The endocaval balloon does not interfere in the sur-
gical field, and no balloon dislocation has been observed.
The introduction in our common practice of endocaval oc-
cluders in redo cases has allowed a significant reduction in
adhesion dissection with minimal blood loss (before 2008,
reoperation for bleeding occurred in 4 cases, whereas only
1 case occurred after 2008). Moreover, it avoids air entrap-
ment in the venous line and the risk of arterial microembo-
lism events, which are more common in case of right atrium
opening using vacuum assist without caval snaring.
In our series, we report a cumulative 30-day mortality rate
of 7.8%. This is in line with other published data with1000 The Journal of Thoracic and Cardiovascular Surmortality rates ranging from 4% to 22%.4,14,23,26,27 Lee
and colleauges22 report a low mortality rate at 30 days
(2.1%) combining repair and replacement. Our results
show a mortality rate of 2.8% and 13.8% for TV repair
and replacement, respectively. In TV replacement, predictive
mortality is 14.12% 13.23%. Other authors have reported
series with higher mortality rates with TV replacement.28,29
The mortality rate in our study is 0% for isolated TV
surgeries and 10.4% for combined procedures. Rankin and
colleagues30 report from the Society of Thoracic Surgeons
database a 30-day mortality rate of 10.7% for isolated TV
surgeries versus 10.8% for combined MV procedures.
Unlike other reports,22,28,31 the overall survival at 5 years
in our series is higher: ranging from 81.3% to 94.1% for
patients undergoing TV surgery alone and 76.6% for
patients undergoing combined surgery (P ¼ .17). No
statistical difference was observed in terms of late
survival for isolated TV surgeries versus combined
procedures. In addition, overall freedom from reoperation
was 100% at 5 years. Complete echocardiographic and
clinical follow-up confirmed optimal results with a signifi-
cant improvement in functional class and no residual regur-
gitation in more than 95% of the cases. Early and late
outcomes suggest that the minimally invasive approach to
tricuspid surgery is safe and effective.Study Limitations
This is a single-center retrospective study, and a small
number of patientswere treated.A longer follow-up is needed
to confirm long-term results and TV repair durability. Other
limitations to the use of this surgical approach are mainly
related to a prolonged learning curve and the cost of the de-
vices. Embolism of air remains a concern when left cardiac
cavities are opened. Careful de-airing can reduce this risk.
Moreover, the operating field can be continuously flooded
with carbon dioxide using a special trocar that allows the in-
sertion of both a venting cannula and a carbon dioxide line.CONCLUSIONS
In this series of high-risk patients undergoing TVopera-
tions, the minimally invasive approach is safe, feasible, and
effective; ensures low perioperative morbidity and mortal-
ity; and ensures low rates of recurrent TR and late mortality.
The nonsternotomy minimally invasive technique has
become the standard of care at the University of Turin for
isolated or combined TV procedures, especially in case of
redo procedures.
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